Pharmaceutical & Drug Policy
When cheap becomes fragile: How the race to the bottom in generics undermines manufacturing quality and what to do about it
The Center on Health Policy produces rigorous evidence and analysis to inform health care policy debates.
The Center on Health Policy produces rigorous evidence and analysis to inform health care policy debates.
Marta E. Wosińska
March 24, 2026
Marta E. Wosińska
March 19, 2026
Marta E. Wosińska
March 18, 2026
Richard G. Frank, Chloe Zilkha
March 17, 2026